If someone with heart disease has their bad cholesterol (LDL) well controlled under 100, then their triglyceride and sugar levels (TyG) don’t seem to add much extra risk for heart problems.
Scientific Claim
The association between a higher triglyceride-glucose index (TyG) and increased cardiovascular risk is significantly weaker or absent in individuals with low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL.
Original Statement
“A higher TyG index did not associate with the primary endpoint in individuals with LDL levels < 100 mg/dL.”
Evidence Quality Assessment
Claim Status
appropriately stated
Study Design Support
Design cannot support claim
Appropriate Language Strength
association
Can only show association/correlation
Assessment Explanation
The abstract uses 'did not associate with', which correctly reflects observational data. No causal language is used. Based on abstract only - full methodology not available to verify
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.
Systematic Review & Meta-AnalysisLevel 1aWhether the attenuation of TyG’s association with cardiovascular events in low-LDL populations is consistent across studies and whether it holds after adjusting for statin use and other lipid-lowering therapies.
Whether the attenuation of TyG’s association with cardiovascular events in low-LDL populations is consistent across studies and whether it holds after adjusting for statin use and other lipid-lowering therapies.
What This Would Prove
Whether the attenuation of TyG’s association with cardiovascular events in low-LDL populations is consistent across studies and whether it holds after adjusting for statin use and other lipid-lowering therapies.
Ideal Study Design
A meta-analysis of 10+ prospective cohorts with individual participant data, stratifying by baseline LDL (<100 vs ≥100 mg/dL), adjusting for statin use, diabetes, and renal function, and reporting interaction p-values for TyG × LDL on composite cardiovascular outcomes.
Limitation: Cannot determine if lowering LDL causally removes TyG’s predictive value.
Prospective Cohort StudyLevel 2bIn EvidenceWhether TyG predicts cardiovascular events differently in patients with LDL <100 mg/dL versus ≥100 mg/dL within the same population.
Whether TyG predicts cardiovascular events differently in patients with LDL <100 mg/dL versus ≥100 mg/dL within the same population.
What This Would Prove
Whether TyG predicts cardiovascular events differently in patients with LDL <100 mg/dL versus ≥100 mg/dL within the same population.
Ideal Study Design
A prospective cohort of 8,000 patients with stable cardiovascular disease, stratified by baseline LDL (<100 vs ≥100 mg/dL), measuring TyG at baseline, and following for 5+ years for cardiovascular events, using interaction terms in Cox models to test effect modification by LDL.
Limitation: Observational; cannot prove LDL control causes attenuation of TyG risk.
Randomized Controlled TrialLevel 1bWhether actively lowering LDL to <100 mg/dL reduces the predictive power of TyG for future cardiovascular events.
Whether actively lowering LDL to <100 mg/dL reduces the predictive power of TyG for future cardiovascular events.
What This Would Prove
Whether actively lowering LDL to <100 mg/dL reduces the predictive power of TyG for future cardiovascular events.
Ideal Study Design
A double-blind RCT of 3,000 adults with stable cardiovascular disease and baseline LDL ≥100 mg/dL, randomized to intensive LDL-lowering (e.g., high-dose statin + ezetimibe) vs standard therapy, measuring TyG at baseline and 12 months, and assessing whether the association between TyG and cardiovascular events differs by treatment group over 5 years.
Limitation: Ethical and practical challenges in randomizing to LDL targets; may not reflect real-world management.
Evidence from Studies
Supporting (1)
This study found that for people with already low 'bad' cholesterol (LDL), their triglyceride and sugar levels (TyG) didn’t predict heart problems as well — meaning TyG isn’t as useful for predicting risk when LDL is under control.